Online Exclusives

Online Exclusives

European CHMP Recommends Approval for Front-line Use of Ibrutinib for CLL

Europe’s Committee for Medicinal Products for Human Use (CHMP) has recommended ibrutinib as a single agent for front-line use in patients with chronic lymphocytic...

ESMO Releases Statement in Support of Biosimilars, Citing Cost-Savings and Cost-Effectiveness

The European Society for Medical Oncology (ESMO) published a position paper in support of biosimilar agents, noting that they are effective, affordable, and, according...

Less-Frequent Dosing of Zoledronic Acid Maintains Efficacy, Improves Safety for Myeloma Patients

Recent guidelines suggest that zoledronic acid – a third-generation aminobisphosphonate used to treat certain bone disease, including multiple myeloma (MM) – should be administered...

Pioglitazone Plus Imatinib Leads to Molecular Response in Patients With Chronic-Phase Chronic Myeloid Leukemia

For patients with chronic-phase chronic myeloid leukemia (CML) treated with imatinib, adding the diabetes 2 medication pioglitazone to treatment could deepen molecular response, according...

New Ruling Will Fine Drug Companies for Overcharging 340B Hospitals

The Department of Health & Human Services (HHS) issued a new rule that imposes a $5,000 fine on drug companies each time they “knowingly...

NCI Attempts to Speed Up Clinical Trials With New “Virtual Formulary” Partnership

As part of the Cancer Moonshot Initiative, the National Cancer Institute (NCI) launched a “virtual formulary” in an effort to speed up clinical trials...

VA Recommends Allowing Advanced Practice Nurses to Practice Independently

The Department of Veterans Affairs (VA) has proposed a rule that would grant full practice authority to all VA advanced practice registered nurses (APRNs)...

Alemtuzumab Improves Survival in Patients With Chronic Lymphocytic Leukemia

An open-label, phase II study published in the British Journal of Haematology found that, in patients with chronic lymphocytic leukemia (CLL) who achieved negative...

Pediatric Patients With Down Syndrome and ALL Can Be Safely, Effectively Treated With Standard...

Treatment modifications and dose reductions are common strategies in managing pediatric patients with Down syndrome and acute lymphocytic leukemia (ALL). According to results from...

Researchers Develop Nanoscale Ultrasound Procedure for Cancer Research

Researchers at the University of Nottingham in the United Kingdom have developed an ultrasound imaging technique that uses sound rather than light to view...
Advertisement

Current Issue

February 2020, Volume 6, Issue 3

This issue examines the high price of treating hemophilia, asks whether CAR T-cell therapies are worth the cost, and more.